IE 11 is not supported. For an optimal experience visit our site on another browser.

FDA approves first treatment for postpartum depression


The FDA has approved a new medication called Zulresso, a completely new class of drug designed specifically to treat postpartum depression. It’s a one-time infusion given in a hospital over two and a half days.